- Home
- BSX vs PRME Comparison
BSX vs PRME Comparison
Compare BSX & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSX
- PRME
- Stock Information
- Founded
- BSX 1979
- PRME 2019
- Country
- BSX United States
- PRME United States
- Employees
- BSX N/A
- PRME N/A
- Industry
- BSX Medical/Dental Instruments
- PRME Medicinal Chemicals and Botanical Products
- Sector
- BSX Health Care
- PRME Health Care
- Exchange
- BSX Nasdaq
- PRME Nasdaq
- Market Cap
- BSX 138.4B
- PRME N/A
- IPO Year
- BSX 1992
- PRME 2022
- Fundamental
- Price
- BSX $102.73
- PRME $1.60
- Analyst Decision
- BSX Strong Buy
- PRME Strong Buy
- Analyst Count
- BSX 23
- PRME 8
- Target Price
- BSX $110.57
- PRME $13.25
- AVG Volume (30 Days)
- BSX 10.3M
- PRME 1.7M
- Earning Date
- BSX 04-23-2025
- PRME 05-09-2025
- Dividend Yield
- BSX N/A
- PRME N/A
- EPS Growth
- BSX 15.23
- PRME N/A
- EPS
- BSX 1.37
- PRME N/A
- Revenue
- BSX $17,554,000,000.00
- PRME $2,983,000.00
- Revenue This Year
- BSX $15.77
- PRME $56.92
- Revenue Next Year
- BSX $10.33
- PRME $150.59
- P/E Ratio
- BSX $75.05
- PRME N/A
- Revenue Growth
- BSX 19.36
- PRME N/A
- 52 Week Low
- BSX $70.97
- PRME $1.12
- 52 Week High
- BSX $107.17
- PRME $8.27
- Technical
- Relative Strength Index (RSI)
- BSX 61.22
- PRME 47.77
- Support Level
- BSX $92.70
- PRME $1.20
- Resistance Level
- BSX $102.37
- PRME $1.86
- Average True Range (ATR)
- BSX 2.95
- PRME 0.17
- MACD
- BSX 1.17
- PRME 0.07
- Stochastic Oscillator
- BSX 97.14
- PRME 65.10
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.